RESPONDER-HF Clinical Trial: A Device to Reduce Heart Failure Symptoms

Trial ID:
IRB-23-8106
Rajeev Mohan, MD

Inclusion Criteria

Patients must:

  • - be age 40 or older
    - have chronic symptomatic heart failure
    - have an LVEF of 40% or more

Exclusion Criteria

Patients must not:

  • - have a cardiac rhythm device such as a pacemaker or CRT
    - have severe valve disease
    - have anemia with hemoglobin less than 10 g/dl (controlled ok)
    - be participating in another clinical trial

Additional Info

A small cardiac device, implanted between your atria, decreases pressure in the left side of the heart and lungs to reduce heart failure symptoms. This is a randomized (device implant vs no device implant), double-blinded study. You and your treating physician will not know if you've received the device. You will be unblinded at your 2-year visit. At that time, participants who did not receive a device may have the opportunity to receive one. Study duration is 5 years.

All treatments and follow-ups will take place at Anderson Medical Pavillion at Scripps Memorial, La Jolla.

The NCT # 05425459 can be used to research more details on
the ClinicalTrials.gov website (https://clinicaltrials.gov)

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org